MCP compliance catalog

Every MCP tool in the SCOPE compliance index, grouped by server — risk posture, regulatory exposure, and the tools that warrant tighter governance.
303MCP servers
4476tools
Reset 303 of 303 servers
Guidepoint
5 tools · footprint 10
2 med 3 low
isolved People Cloud
6 tools · footprint 10
2 med 4 low
Lightfield
5 tools · footprint 10
2 med 3 low
Shopify
6 tools · footprint 10
1 med 5 low
Swagger (SmartBear)
25 tools · footprint 10
10 med 15 low
Benchling
4 tools · footprint 9
2 high 2 med
Boltz
11 tools · footprint 9
7 med 4 low
CargoAi
6 tools · footprint 9
1 med 5 low
ClinicalTrials.gov Connector
6 tools · footprint 9
1 med 5 low
Exa
7 tools · footprint 9
1 med 6 low
Exa
4 tools · footprint 9
1 med 3 low
FactSet AI-Ready Data
18 tools · footprint 9
1 med 17 low
HubSpot Developer MCP Server (App & CMS Development)
21 tools · footprint 9
4 med 17 low
Indeed
4 tools · footprint 9
1 med 3 low
Canary Data
14 tools · footprint 8
14 low
Google Contacts (People API MCP Server)
3 tools · footprint 8
3 low
‹ PrevPage 13 of 19Next ›
AdisInsight
4 low · 4 tools · 0 SoD-flagged
regimes none

Tools needing tighter control (0 of 4)

None — every tool is low-risk, high-confidence, and outside PCI/HIPAA payload scope.
All other tools (4)
adisinsight.get_drug low conf mediumallow
Returns a full drug profile including development history, aggregate adverse-event data, organizations, and brand names from the Adis intelligence database.
adisinsight.get_trial low conf mediumallow
Returns a complete clinical-trial profile including investigators, study centres, compounds, indications, endpoints, and eligibility criteria from published trial intelligence.
adisinsight.search_drugs low conf mediumallow
Queries the Adis pharmaceutical database across drug name, therapeutic area, developer, mechanism, phase, and 60+ filters, returning commercial drug-intelligence results only.
adisinsight.search_trials low conf mediumallow
Searches clinical-trial records by condition, sponsor, compound, phase, status, and demographic criteria, exposing competitive trial-intelligence but no individual patient records.